Straumann Holding AG | Income Statement

Fiscal year is January-December. All values CHF Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
680
710
799
918
1,112
1,364
Cost of Goods Sold (COGS) incl. D&A
144
152
184
199
272
344
Gross Income
536
559
615
719
840
1,019
SG&A Expense
421
413
442
494
560
680
EBIT
115
146
172
225
280
339
Unusual Expense
1
-
2
-
16
-
Non Operating Income/Expense
4
2
77
1
72
4
Interest Expense
4
4
4
4
6
8
Pretax Income
114
141
92
224
333
336
Income Tax
19
20
9
7
48
49
Equity in Affiliates
6
36
12
2
10
10
Consolidated Net Income
101
158
72
230
276
278
Net Income
101
158
71
230
273
273
Net Income After Extraordinaries
101
158
71
230
273
273
Net Income Available to Common
101
158
71
230
273
273
EPS (Basic)
6.55
10.15
4.52
14.68
17.61
17.24
Basic Shares Outstanding
15
16
16
16
15
16
EPS (Diluted)
6.50
10.03
4.47
14.60
17.53
17.18
Diluted Shares Outstanding
16
16
16
16
16
16
EBITDA
147
174
205
257
320
392
Non-Operating Interest Income
-
1
3
2
2
1
Minority Interest Expense
-
-
1
-
3
5

About Straumann Holding

View Profile
Address
Peter Merian-Weg 12
Basel Basel-Stadt (Basle Town) 4002
Switzerland
Employees -
Website http://www.straumann.com
Updated 07/08/2019
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging Markets EMEA, Sales NAM, Sales APAC, Sales LATAM, and Operations. The Sales Europe segment comprises of the Group's premium and Instradent distribution business.